Related Experiment Video
Updated: Jul 15, 2025
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Anti-inflammatory effects of yeast-derived vacuoles on LPS-induced murine macrophage activation
Su-Min Lee1, Yang-Hoon Kim2, Jiho Min1
1Graduate School of Semiconductor and Chemical Engineering, Jeonbuk National University , Jeonbuk, South Korea.
Importance:
This study investigates the potential of using vacuoles derived from the yeast Saccharomyces cerevisiae as a new anti-inflammatory therapy. Inflammation is a natural response of the immune system to invading pathogens, but when it is dysregulated, it can lead to chronic diseases. The researchers found that treating macrophages with vacuoles significantly reduced the production of pro-inflammatory cytokines and iNOS, markers of inflammation when they were stimulated with lipopolysaccharide. The study also showed that vacuoles inhibited the NF-κB signaling pathway, which is involved in the induction of pro-inflammatory cytokines in macrophages. These findings suggest that S. cerevisiae-derived vacuoles may have potential as a new therapeutic agent for regulating the inflammatory response in various diseases. Further studies are needed to evaluate the efficacy and safety of vacuoles in vivo and to elucidate the underlying mechanisms of their anti-inflammatory effects.
Insights
Vacuoles from Saccharomyces cerevisiae yeast show significant anti-inflammatory effects by reducing key inflammatory mediators and inhibiting the NF-κB pathway in macrophages, suggesting potential therapeutic applications for inflammatory diseases.
Area of Science:
- Immunology
- Microbiology
- Biochemistry
Background:
- Vacuoles from Saccharomyces cerevisiae share functional similarities with mammalian lysosomes.
- Dysregulated inflammation is implicated in various chronic diseases.
- Lipopolysaccharide (LPS) is a potent inducer of inflammatory responses in macrophages.
Purpose of the Study:
- To evaluate the anti-inflammatory efficacy of Saccharomyces cerevisiae-derived vacuoles.
- To investigate the modulation of inflammatory mediators and signaling pathways by these vacuoles.
Main Methods:
- Treatment of macrophages with varying concentrations of S. cerevisiae-derived vacuoles.
- Assessment of inflammatory mediator expression (iNOS, TNF-α, IL-1β, IL-6) via protein and mRNA analysis.
- Immunofluorescence analysis to track nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) translocation.
Main Results:
- S. cerevisiae-derived vacuoles significantly inhibited LPS-induced expression of iNOS protein and mRNA.
- Vacuoles markedly reduced mRNA levels of TNF-α, IL-1β, and IL-6 in LPS-stimulated macrophages.
- Vacuoles suppressed NF-κB pathway activation in LPS-stimulated macrophages.
Conclusions:
- S. cerevisiae-derived vacuoles demonstrate potent anti-inflammatory properties by downregulating the NF-κB pathway.
- These findings highlight the potential of S. cerevisiae-derived vacuoles as a novel therapeutic agent for inflammatory conditions.
- Further in vivo studies are warranted to confirm efficacy and safety.
More Related Videos
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
08:34Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
Published on: February 22, 2017